As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ERROR 2

Yes! I want to get the latest chemistry news from C&EN in my inbox every week.

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

Chemical companies are closing plants and abandoning projects as the impact of COVID-19 deepens. Solvay will close composite materials facilities in Manchester, England, and Tulsa, Oklahoma, in response to a drop in demand resulting from COVID-19. About 570 employees—20% of Solvay’s composites workforce—are set to lose their jobs as a result of the closures, along with other positions across the business. Solvay says the measures will cost $32 million but generate annual savings of $64 million. Borealis has ditched plans for a $6.8 billion petrochemical project in Atyrau, Kazakhstan, featuring a steam cracker and polyethylene plant because of the effects of the pandemic and an increasingly uncertain market outlook. The complex had been scheduled to start up in 2026. Meanwhile, Arkema recently reduced its planned capital expenditures for 2020 by $108 million and its fixed costs by $54 million to help it weather market conditions caused by COVID-19. Lanxess has cut its planned capital spending for 2020 by $54 million.